We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
MiMedx is suing wound-treatment competitor Osiris Therapeutics, accusing it of falsely claiming in a press release that its biologic is superior to MiMedx’s product. Read More
Amgen is suing generics maker Sandoz, claiming that Sandoz’s attempts to market a biosimilar for the blockbuster bone marrow drug Neulasta infringes on two of its patents for the drug. Read More
The FDA wants clinical researchers to improve their electronic data capture systems to ensure interoperability with electronic health records used by health care organizations. Read More